Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort

Diabetic Medicine

Volumn 29, Issue 4, 2012, Pages 541-548

  Sanz, C M ^a,b,c   Hanaire, H ^a,c   Vellas, B J ^a,b,c   Sinclair, A J ^d   Andrieu, S ^a,b,c  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

Alzheimer's disease; Disability; Geriatrics

Indexed keywords

ANTIDIABETIC AGENT;

ADL DISABILITY; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GLYCEMIC CONTROL; HAZARD RATIO; HEALTH CARE DELIVERY; HUMAN; LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; POLYPHARMACY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; COHORT STUDIES; DIABETES MELLITUS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OBESITY; POSTURAL BALANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84858214548     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03445.x     Document Type: Article

References (29)

1. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: International Diabetes Federation, ed. Diabetes Altas. 4th edition. Brussels: International Diabetes Federation, 2010: 1-105.
2. Brookmeyer R, Johnson E, Ziegler-Grahamb K, Arrighic H. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3: 186-191.
3. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens PC. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74.
4. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 1999; 48: 445-469.
5. Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes Care 2008; 31: 233-235.
6. Regan C, Katona C, Walker Z, Hooper J, Donovan J, Livingston G. Relationship of vascular risk to the progression of Alzheimer disease. Neurology 2006; 67: 1357-1362.
7. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Micas M, Ousset PJ et al. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 2003; 7: 91-96.
8. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. J Am Med Assoc 1963; 185: 914-919.
9. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
10. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
11. Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc 1997; 45: 735-738.
12. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999; 15: 116-122.
13. Gregg EW, Mangione CM, Cauley JA, Thompson TJ, Schwartz AV, Ensrud KE et al. Diabetes and incidence of functional disability in older women. Diabetes Care 2002; 25: 61-67.
14. Volpato S, Ferrucci L, Blaum C, Ostir G, Cappola A, Fried LP et al. Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study. Diabetes Care 2003; 26: 70-75.
15. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004; 17: 309-318.
16. Strotmeyer ES, de Rekeneire N, Schwartz AV, Faulkner KA, Resnick HE, Goodpaster BH et al. The relationship of reduced peripheral nerve function and diabetes with physical performance in older white and black adults: the Health, Aging, and Body Composition (Health ABC) study. Diabetes Care 2008; 31: 1767-1772.
17. Resnick HE, Vinik AI, Schwartz AV, Leveille SG, Brancati FL, Balfour J et al. Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care 2000; 23: 1642-1647.
18. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006; 29: 2539-2548.
19. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70: 935-942.
20. Sherrington C, Whitney JC, Lord SR, Herbert RD, Cumming RG, Close JC. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc 2008; 56: 2234-2243.
21. Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S et al. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc 2007; 55: 158-165.
22. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O'Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22: 1479-1486.
23. Hanlon JT, Fillenbaum GG, Kuchibhatla M, Artz MB, Boult C, Gross CR et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002; 40: 166-176.
24. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004; 27: 2540-2553.
25. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology 2007; 69: 1850-1858.
26. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R et al. The consortium to establish a registry for Alzheimer's disease (CERAD). PartIV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993; 43: 2457-2465.
27. Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 2009; 73: 1359-1366.
28. Wimo A, Prince M. Alzheimer's Disease International (ADI). World Alzheimer Report 2010. The Global Economic Impact of Dementia. 2010. Available at Last accessed 20 September 2011.
29. American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care 2008; 31: 596-615.